Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection

Clinical Infectious Diseases

Volumn 47, Issue 10, 2008, Pages

  Philip, Susan S ^a   Ahrens, Katherine ^a   Shayevich, Clara ^a   De La Roca, Romeo ^a   Williams, MaryAnn ^a   Wilson, Daniel ^a   Bernstein, Kyle ^a   Klausner, Jeffrey D ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS 2; HERPES SIMPLEX VIRUS 2 INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; VIRUS DETECTION; VIRUS INFECTION; WESTERN BLOTTING;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 54249129283     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592696     Document Type: Article

References (17)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-73.
2. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-13.
3. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
4. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999; 37:376-9.
5. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1-94.
6. Focus Diagnostics. 510(k) Summary of safety and effectiveness: HerpeSelect Express IgG. 2007. Available at: http://www.fda.gov/cdrh/ pdf7/K071510.pdf. Accessed 28 December 2007.
7. Laderman EI, Whitworth E, Dumaual E, et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood. Clin Vaccine Immunol 2008; 15:159-63.
8. Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis 2005; 40:38-45.
9. Golden MR, Ashley-Morrow R, Swenson P, Hogrefe WR, Handsfield HH, Wald A. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis 2005; 32:771-7.
10. Ehrich AL, Jespersen DJ, Binnicker MJ. Evaluation of the HerpeSelect Express Rapid Lateral Flow Assay. Pan American Society for Clinical Virology. Clearwater Beach, FL: Pan American Society for Clinical Virology, 2007.
11. Miyai T, Turner KR, Kent CK, Klausner J. The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis 2004; 31:517-21.
12. Wilkinson D, Barton S, Chard S, Meadows J. The psychological consequences in patient undergoing a POCKit HSV-2 test. Int J STD AIDS 2000; 11:551-2.
13. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10:530-6.
14. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002; 9:38-45.
15. Ly TD, Malkin JE, Bohbot JM. Performance of a rapid screening test POCkit HSV2 Rapid Test. Int J STD AIDS 1999; 10:68.
16. Turner KR, Wong EH, Kent CK, Klausner JD. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis 2002; 29:422-5.
17. Warren T, Ebel C. Counseling the patient who has genital herpes or genital human papillomavirus infection. Infect Dis Clin North Am 2005; 19:459-76.